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doi:10.1016/j.ejvs.2010.01.001Abstract Introduction: Contrast-enhanced computed tomography (CT) has become the
‘gold-standard’ imaging modality for surveillance following EVAR. However repeated CT causes
cumulative contrast related renal injury. Duplex ultrasound (USS) and contrast-enhanced (non-
nephrotoxic) duplex scanning (CEUS) are less invasive but considered less accurate than CT.
The aim of this study was to determine the diagnostic accuracy of imaging modalities used
to detect endoleak. Accordingly, we undertook a systematic review and meta-analysis of
the evidence base for USS and CEUS compared to CT following EVAR.
Methods: Medline, Embase, trial registries, conference proceedings and article reference lists
were searched to identify trials comparing USS or CEUS with CT following EVAR. Contrast-
enhanced computed tomography was taken as the ‘gold-standard’ investigation. USS and CEUS
were compared to CT in separate meta-analyses.
Results: Twenty-one studies in 2601 patients compared USS with CT. The sensitivity of USS at
detecting endoleak was 0.77 (95% CI 0.64e0.86; I2Z 0.82) and pooled specificity 0.94 (95% CI
0.88e0.97; I2Z 0.90). Seven studies (288 patients) compared CEUS vs CT. The pooled sensi-
tivity was 0.98 (95% CI 0.90e0.99; I2Z 0.32) and specificity 0.88 (95% CI 0.78e0.94;
I2Z 0.67).
Conclusion: This study confirms that unenhanced USS has poor sensitivity for endoleak detec-
tion; however CEUS is a highly sensitive modality. These results should be interpreted withting 3e6 September, 2009, European Society for Vascular Surgery, Oslo, Norway.
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Duplex Ultrasound and Contrast-Enhanced Ultrasound Versus Computed Tomography 419some caution due to heterogeneity in analysed trials and further research is needed to eval-
uate the efficacy of CEUS before it can be utilised as the primary imaging modality for EVAR
surveillance.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Endovascular aneurysm repair (EVAR) was first described in
19911 and is associated with fewer cardiac, respiratory, and
hemorrhagic complications than open aneurysm repair and
requires a shorter hospital stay.2 Subsequently, high-quality
evidence has demonstrated favourable short-term
mortality benefits for EVAR compared to open repair.3
However, endoleak, migration and other endograft related
complications following EVAR require long-term post-oper-
ative surveillance. The importance of these long-term risks
is highlighted by recently presented data from the DREAM
trial that shows greater 5-year post-discharge mortality in
patients treated by EVAR compared with those undergoing
open aneurysm repair.4 Endoleak in particular carries great
significance, as it is predictive of post-EVAR rupture,5 and
therefore, post-EVAR endoleak surveillance has become
mandatory.
Endoleak is defined as the flow of blood within the
aneurysm sac but outside the endovascular graft. At
present contrast-enhanced spiral computed tomography
(CT) angiography with specialized 3D reconstruction is
considered as the gold-standard for endoleak surveillance.6
CT angiography is efficient in defining the anatomy of
aneurysm sac, detection of endoleak and its classification
but factors such as a high dose of radiation with risk of skin
malignancy,7 administration of nephrotoxic contrast8 and
high cost9 are the main limitations of its use as a lifelong
surveillance tool.
Duplex ultrasound is being investigated as an alternative
to CT for the follow-up of EVAR patients. This modality is
less expensive and does not carry the risks associated with
ionizing radiation or contrast induced nephrotoxicity.
Researchers have also augmented duplex ultrasound with
non-nephrotoxic contrast agents to detect post-EVAR
endoleak and have claimed promising results.10,11
The aim of this meta-analysis is to update the sensitivity
and specificity values of duplex ultrasound and contrast-
enhanced duplex ultrasound in comparison to CT, which
remains the existing gold-standard for endoleak
detection.12,13Methods
An electronic search was performed using the Embase and
Medline databases from 1996 until 2009, to identify studies
comparing concurrent CT and USS for the detection of
endoleak after EVAR. The search terms ‘‘USS’’, ‘‘CT’’,
‘‘vascular’’, ‘‘EVAR’’, ‘‘endoleak’’ and MeSH headings
‘‘ultrasonography’’[MeSH], ‘‘Tomography, X-Ray Compu-
ted’’[MeSH], and ‘‘Vascular Surgical Procedures’’[MeSH]
were used in combination with the Boolean operators AND
or OR. Two authors independently performed electronicsearches in March 2009. The electronic search was supple-
mented by a hand search of published abstracts from
meetings of the Vascular Society of Great Britain and
Ireland from 1989 to 2008, the International Congress on
Endovascular Interventions from 1996 to 2009, the Society
for Vascular Surgery from 2005 to 2009 and the Peripheral
Vascular Surgery Society from 1998 to 2009. The reference
lists of articles obtained were also searched to identify
further relevant citations. Finally, the search included the
Current Controlled Trials Register (www.controlled-trials.
com) and, the DARE database and the Cochrane Database
of Controlled Trials.
Contrast-enhanced computed tomography was taken as
the ‘gold-standard’ investigation. Standard duplex ultra-
sound and contrast-enhanced duplex ultrasound were
compared to CT in separate meta-analyses. Inclusion
criteria comprised English language studies which reported
the detection of endoleak in greater than 10 concurrent
USS and CT examinations of unselected patients after EVAR.
For inclusion, all studies had to provide sufficient individual
patient data to allow the determination of both true and
false positives and negatives in 2 2 contingency tables.
Study retrieval was conducted according to the QUORUM
protocol (QUORUM diagram). Studies which had insufficient
data to enable generation of contingency tables were
excluded, and the QUADAS scoring tool14 was used in
duplicate by two authors (TAM and AK) for quality assess-
ment. Where necessary, differences in QUADAS score were
resolved by a third reviewer (JB).
Statistical analysis
A sensitivity and specificity pair was calculated for each
eligible study. Initial meta-analysis was conducted using
a fixed-effects model and the sensitivityespecificity pairs
for each study were then plotted graphically to generate
a summary receiver operating characteristic (ROC) curve.
The area under the curve, a global reflection of diagnostic
accuracy with a theoretical range of 0e1, was calculated
together with its standard error. Heterogeneity was
assessed by means of the I2 statistic. This initial statistical
analysis was performed using Meta-DiSc Version 1.415 from
which all I2 statistics quoted in this article were obtained.
However, it has been suggested that a bivariate model
for meta-analysis of statistical accuracy provides more
accurate results.16,17 The primary analyses were therefore
repeated following peer review, using bivariate meta-
analysis with hierarchical summary ROC curve analysis
following the validated methodology of Harbord et al.16 to
generate pooled point estimates for sensitivity and speci-
ficity with 95% confidence intervals, together with a hier-
archical summary ROC curve. The software used for this
analysis was a custom-designed statistical package
420 T.A. Mirza et al.developed by Harbord and Whiting.18 Similar estimates
were obtained, but somewhat wider confidence intervals
resulted from these re-analyses, so we provide quantitative
results from the bivariate model wherever this analyses was
performed. In order to assess whether there is any evidence
of publication bias, funnel plots were constructed and
inspected for asymmetry.
Results
Unenhanced ultrasound
Twenty-one studies provided sufficient data for inclusion in
this meta-analysis (Table 1). Overall, unenhanced duplex
was compared to the gold-standard of contrast-enhanced
CT in 2601 patients. From the bivariate meta-analysis,16 the
pooled sensitivity was 0.77 (95% CI 0.64e0.86; I2Z 0.82)
and pooled specificity was 0.94 (95% CI 0.88e0.97;
I2Z 0.90) (Fig. 1). The summary ROC curve plotted using
fixed-effects meta-analysis had an area under the curve of0.91 (standard error 0.03). Visual inspection of the funnel
plot revealed no asymmetry to indicate statistical evidence
of publication bias.
Enhanced ultrasound
Seven studies (285 patients) provided sufficient data for
inclusion in this analysis (Table 2). From the bivariate meta-
analysis,16 the pooled sensitivity was 0.98 (95% CI 0.90e
0.99; I2Z 0.32). The pooled specificity was 0.88 (95% CI
0.78e0.94; I2Z 0.67) (Fig. 2). The summary ROC curve
plotted using fixed-effects meta-analysis had an area under
the curve of 0.96 (standard error 0.02). Visual inspection of
the funnel plot revealed no asymmetry to indicate statis-
tical evidence of publication bias.
Sensitivity analyses
To analyse for the confounding effect of CEUS equipment
being more modern than unenhanced USS, sensitivity
Table 1 Studies included in comparison of unenhanced duplex to CT, with contingency tables of diagnostic accuracy.
Study Scan pairs CTþUSSþ CTþUSS CTUSSþ CTUSS
Heilberger et al., 199736 34 8 1 0 25
Sato, 199837 117 33 7 18 59
Thompson et al., 199838 20 4 0 0 16
Wolf et al., 200039 166 51 12 3 100
Zannetti et al., 200040 198 11 1 3 183
d’Audiffret et al., 200141 211 31 1 4 175
Pages, 200142 109 14 15 5 75
Greenfield et al., 200243 11 6 1 1 3
McLafferty et al., 200244 76 7 0 1 68
McWilliams et al., 200245 96 2 18 4 72
Parent et al., 200246 141 18 0 18 105
Bendick et al., 200310 20 6 2 0 12
Giannoni et al., 200347 78 5 3 0 70
Raman et al., 200348 494 21 28 18 427
AbuRahma et al., 200549 367 23 11 4 329
Ashoke et al., CC, 200513 66 4 2 12 48
Ashoke et al., SG, 200513 23 6 1 3 13
Sandford et al., 200650 244 15 12 18 199
Henao et al., 200621 20 3 3 1 13
Collins et al., 200719 35 10 3 14 8
Iezzi et al., 200920 84 25 15 16 28
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published prior to 2003 were excluded. Fairly similar results
were obtained for unenhanced ultrasound (pooled sensitivity
0.59; 95% CI 0.52e0.66; pooled specificity 0.93; 95% CI 0.92eFigure 1 Plot comparing sensitivity and specificity of ultra-
sound vs CT, illustrating weighted point estimates of individual
studies, pooled point estimate from bivariate meta-analysis,
hierarchical summary ROC curve and elliptical 95% confidence
interval of pooled estimate.0.94) and contrast-enhanced ultrasound (pooled sensitivity
0.89; 95% CI 0.80e0.95; pooled specificity 0.94; 95% CI 0.89e
0.97). To analyse for a confounding effect of trials with poor
QUADAS score (Table 3), sensitivity analysis was performed
with the lowest-scoring trial removed from analysis.19 The
resulting point estimates of pooled sensitivity and specificity
were unchanged to two decimal places.
Discussion
The point estimates for pooled sensitivity and specificity
from bivariate meta-analysis suggest that contrast-
enhanced ultrasound has superior sensitivity compared to
unenhanced ultrasound for the detection of endoleak after
EVAR. The higher area under the summary ROC curve for
contrast-enhanced ultrasound also suggests that this
modality is superior. However, these results must be
interpreted with some caution. There is significant
heterogeneity among the studies. This partly arises from
inherent inter- and intra-observer variation in studies of
diagnostic imaging techniques (ultrasound in particular is
very operator dependent). It may also arise from variation
in instrument quality, particularly in the earlier studies
with less advanced ultrasound equipment. Furthermore, in
two studies the ultrasound operator was not blinded to the
results of post-operative CT scanning, and this information
was unclear in six studies, introducing potential observer
bias and lowering the QUADAS score of contributing trials
(Table 3). Few trials reported inter-observer variability for
within-group consideration of the diagnostic accuracy of
USS and no trials reported statistical comparison of CEUS
with USS (Table 4).
Five of the seven studies of contrast-enhanced ultra-
sound were published in 2003 onwards, compared to only 10
of the 21 studies of unenhanced ultrasound. This raises the
possibility that more advanced instrumentation may
Table 2 Studies included in analysis of contrast-enhanced ultrasound vs CT
Study Contrast agent used Scan pairs CTþCEUSþ CTþCEUS CTCEUSþ CTCEUS
Heilberger et al., 199736 LevoVist (99.9% galactose
and 0.1% palmitic acid)
34 8 1 1 24
McWilliams et al., 199951 LevoVist 20 3 0 6 11
Bendick et al., 200310 Optison (gas-filled microspheres of
heat-denatured human albumin)
20 8 0 2 10
Giannoni et al., 200347 LevoVist 78 8 0 3 67
Henao et al., 200621 Optison 20 6 0 3 11
Giannoni et al., 200711 Sono Vue (sulphur hexafluoride gas,
stabilised by phospholipids)
29 7 0 1 21
Iezzi et al., 200920 SonoVue 84 39 1 8 36
422 T.A. Mirza et al.account for the apparent superiority of contrast-enhanced
ultrasound. To explore this, a sensitivity analysis was per-
formed in which studies published prior to 2003 were
excluded. Similar results were obtained for unenhanced
ultrasound and contrast-enhanced ultrasound. Thus, the
apparent superiority of contrast-enhanced ultrasound does
not appear to be an artefact arising from a comparison of
modern to dated equipment.
An initial systematic review of the diagnostic accuracy of
ultrasound in the follow-up of EVAR was performed by
Ashoke et al.13 They highlighted that non-contrast duplex
ultrasound lacks sufficient diagnostic accuracy for sole use
in endoleak detection. However, this analysis did not
include a consideration of contrast-enhanced ultrasound,Figure 2 Plot comparing sensitivity and specificity of
contrast-enhanced ultrasound vs CT, illustrating weighted
point estimates of individual studies, pooled point estimate
from bivariate meta-analysis, hierarchical summary ROC curve
and elliptical 95% confidence interval of pooled estimate.and the evidence base for all modalities has since
increased, warranting renewed analysis incorporating
newer trials. Sun12 published a systematic review high-
lighting initial studies that included contrast-enhanced
ultrasound, and concluded that this promising modality
warranted further study. Our updated meta-analysis
provides a much-needed quantitative analysis of contrast-
enhanced ultrasound, incorporating three high-quality new
studies11,20,21 not previously included in systematic quan-
titative review. Furthermore, the present study represents
the first bivariate meta-analysis of this topic conducted
using optimal statistical methodology and dedicated soft-
ware as recommended by Harbord et al.16,17
Ultrasound offers several potential advantages
compared to CT, including lower cost, radiation exposure,
shorter scan times and most importantly the absence of
nephrotoxicity. However, poor performance of colour
duplex ultrasound in endoleak detection may be due to
patient factors such as unfavourable body habitus, coexis-
tent pathology such as ascites, hernia or excessive inter-
vening bowel gas; and graft factors such as echo reflection
from the stent graft or slow endoleak flow. Conversely,
previous research has suggested that many of these
hindrances can be minimised by the use of ultrasonic
contrast.22 Indeed, the high false-positive rate of contrast-
enhanced ultrasound compared to CT may in fact represent
its higher sensitivity in detection of true low-flow endo-
leaks.10,23 Furthermore, the ultrasonic microbubble
contrast agents employed in studies reviewed (Table 2) are
all safe agents with no known nephrotoxicity.24
Post-EVAR surveillance is required to identify endoleak
and graft migration, but ultimately to guide re-intervention
and prevent rupture. The indication for re-intervention after
EVAR is complex and depends on many characteristics not
identifiable by USS or CEUS including graft migration and limb
kinking. Post-deployment device migration has also been
identified by the EUROSTAR group as a poor prognostic sign.25
Stent-strut failure has been shown to be clinically insignifi-
cant.26 EVAR significantly reduces aneurysm sac pressures.27
Mean intra-sac pressures reduce to 20% of mean arterial
pressure (MAP) following endovascular exclusion.28 A
potential surveillance technique is therefore serial assess-
ment of intra-sac pressure. Long-term non-invasive sac
pressure monitoring has been shown to be feasible and
durable29 and such alternative modalities further add to the
complexity of a complete consideration of the relationship
Table 3 QUADAS score components of individual studies included in meta-analysis.
Spectrum
composition
Selection
criteria
Reference
standard
Disease
progression
bias
Partial
verification
Differential
verification
Incorporation
bias
Index
test
execution
Reference
standard
execution
Test
review
bias
Reference
standard
review bias
Clinical
review
bias
Uninterrpretable
test
result
Withdrawls Total
Sato et al.,
199837
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Thompson
et al.,
199838
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Wolf et al.,
200039
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Zannetti
et al.,
200040
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
d’Audiffret
et al.,
200141
Yes Yes Yes Yes (up to
4 weeks)
Whole
sample
Yes Yes Yes Yes No No Yes Yes Yes 12/14
Pages et al.,
200142
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Greenfield
et al.,
200243
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes No Yes Yes Yes Yes 13/14
McLafferty
et al.,
200244
Yes Yes Yes No (2e5
months)
Whole
sample
Yes Yes Yes Yes UnclearUnclear Yes Yes Yes 11/14
McWilliams
et al.,
200245
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Parent
et al.,
200246
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes UnclearUnclear Yes Yes Yes 11/14
Giannoni
et al.,
200347
Yes Yes Yes Yes
(1 week)
Whole
sample
No (some
had CT
and some
MRA)
Yes Yes Yes Yes Yes Yes Yes Yes 13/14
Raman
et al.,
200348
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
AbuRahma
et al.,
200549
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
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Table 3 (continued)
Spectrum
composition
Selection
criteria
Reference
standard
Disease
progression
bias
Partial
verification
Differential
verification
Incorporation
bias
Index
test
execution
Reference
standard
execution
Test
review
bias
Reference
standard
review bias
Clinical
review
bias
Uninterrpretable
test
result
WithdrawlsTotal
Ashoke
et al.,
CXH,
200513
Yes Yes Yes Not
mentioned
Whole
sample
Yes Yes Yes Yes UnclearUnclear Yes Yes Yes 11/14
Ashoke
et al.,
STGH,
200513
Yes Yes Yes Not
mentioned
Whole
sample
Yes Yes Yes Yes UnclearUnclear Yes Yes Yes 11/14
Sandford
et al.,
200650
Yes Yes Yes No
(6 months)
Random
selection
Yes Yes No No Yes Unclear Yes Yes Yes 9/14
Henao
et al.,
200621
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Collins
et al.,
200719
Yes Yes Yes Unclear Random
selection
No
(CT done
when
USSþ)
Yes No Yes UnclearUnclear Yes No No 6/14
Heilberger
et al.,
199736
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes UnclearUnclear Yes No Yes 11/14
McWilliams
et al.,
199951
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes No 13/14
Bendick
et al.,
200310
Yes Yes Yes Yes
(2 weeks)
Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Giannoni
et al.,
200711
Yes Yes Yes Yes
(2 weeks)
Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
Iezzi et al.,
200920
Yes Yes Yes Yes Whole
sample
Yes Yes Yes Yes Yes Yes Yes Yes Yes 14/14
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Table 4 Methodological characteristics of individual trials included in meta-analysis.
Author, Year CT Type of endograft Positivity criterion for the
presence of endoleak by USS
inter-observer
agreement
examined for
USS detection
of endoleak
Type I or III
endoleaks
reported
separately
Comparison
made between
USS and CEUS
Type of scanner Slice
Thickness
Sato et al., 199837 Not mentioned 3 mm Endovascular
Technologies
Spectral Doppler waveform
outside the graft and
within AAA sac
No No N/A
Thompson et al., 199838 HiQ 10 mm Endovascular Technologies
aortic tube graft, Stentor
bifurcated system
Presence of contrast
within the aneurysm sac
No No N/A
Wolf et al., 200039 CTi single detector or
Lightspeed Qxi multi
detector helical
5 mm AneuRx bifurcated Unclear No No N/A
Zannetti et al., 200040 Spiral or axial 5 mm AneuRx, Gore
Excluder, Talent
Reproducible colour signal
outside the endograft and
within the aneurysmal sac
Yes,
KappaZ 1
No N/A
d’Audiffret et al., 200141 Elscint helical twin
scanner
8 mm Mintec, Vanguard,
AneuRyx, Talent, Stenford
Colour flow outside
endoprosthesis
No Yes N/A
Pages et al., 200142 Somatom Plus-S spiral CT 10 mm EVT, Vanguard,
AneuRx, Endologix
Uptake of contrast between
the graft and aneurysmal sac
No Yes N/A
Greenfield et al., 200243 Advantage Hi-Speed
helical
3 mm Ancure blood flow outside the graft
lumen but within the
aneurysmal sac.
No Yes N/A
McLafferty et al., 200244 Helical 2 mm AneuRx Unclear No Yes N/A
McWilliams et al., 200245 Biphasic enhanced 5 mm Bifurcated with modular
or one piece design
Presence of intra-sac flow
outside the stent graft
No No N/A
Parent et al., 200246 Single detector helical 3 mm EVT-EGS/Guidant-Ancure Presence of contrast inside
the sac but outside
the endograft
No Yes N/A
Giannoni et al., 200347 Somatom Plus-S 3 mm Vanguard bifurcated,
straight Passager,
Vanguard, Parodi devices
Colour flow sampling
outside stent graft,
>2 mm change in sac
diameter
No Yes No
Raman et al., 200348 Lightspeed QXi multi
detector row helical
2.5 mm Ancure, AneuRyx Direct visualization of
perigraft flow into the
aneurysm sac
No Yes N/A
AbuRahma et al., 200549 Helical 3 mm Ancure, AneuRx, Excluder Abnormal flow in the
excluded aneurysm
No Yes N/A
Ashoke et al., CXH, 200513 Not mentioned Not
mentioned
AneuRx, Zenith bifurcated,
Zenith Trifab, EVT
Unclear No Yes N/A
Ashoke et al., STGH, 200513 Not mentioned Not
mentioned
AneuRx, Zenith bifurcated,
Zenith Trifab, EVT
Unclear No Yes N/A
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Table 4 (continued)
Author, Year CT Type of endograft Positivity criterion for the
presence of endoleak by U
inter-observer
agreement
examined for
USS detection
of endoleak
Type I or III
endoleaks
reported
separately
Comparison
made between
USS and CEUS
Type of scanner Slice
Thickness
Sandford et al., 200650 Phillips Secura single
slice helical
Not
mentioned
Not mentioned persistent blood flow
within the aneurysm sac
No Yes N/A
Henao et al., 200621 Lightspeed ultra 1.5 mm Not mentioned Presence of intra-sac flow
outside the stent graft
No Yes N/A
Heilberger et al., 199736 Not mentioned Not
mentioned
Chuter, Stentor, EGS
aortic endograft
Extraluminal flow of
contrast
No No No
McWilliams et al., 199951 High speed helical Not
mentioned
Vanguard, Stentor,
AneuRx
Persistence of blood flow
ouside the graft lumen
but within aneurysm sac
No No No
Bendick et al., 200310 Helical 2e3 mm Modular or unibody
bifurcated (names
not mentioned)
Unclear No Yes No
Giannoni et al., 200711 Delayed triphasic
sequences
Not
mentioned
Excluder-Gore,
Talent-Medtronic
2 mm change in diamete
of aneurysm sac
Yes, Kappa
not reported
Yes No
Iezzi et al., 200920 Multidetector
row helical
1e2.5 mm Talent, Excluder, Zenith,
Vanguard, AneuRx
Colour duplex signals
present
beyond the graft
Yes, Kappa
> 0.89
Yes No
Collins et al., 200719 Toshiba Aquilion
64 Helical
2.5 mm Ancure, AneuRx Unclear No Yes N/A
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consideration of the utility of CEUS or USS as the sole imaging
modality for direction of re-intervention after EVAR is
therefore clearly beyond the scope of the present meta-
analysis. Type II endoleak alone is increasingly managed
conservatively, and a limitation of the present study is that
separate analysis by subtype of endoleak was not conducted.
Evidence suggests that the risk of post-EVAR re-intervention
is heterogeneous and that identification of a high-risk
subgroup requiring intensive surveillance will depend on
further study of aneurysm morphology.30,31 In the light of
these hypotheses, further study of the accuracy of CEUS for
identifying type I and III endoleaks and its implications for re-
intervention will need quantification using prospective trial
design. The methodological quality of included trials is
a further theoretical limitation of this meta-analysis, as was
its limitation to the English language literature. However,
sensitivity analysis by removal of the trial with the lowest
QUADAS score19 did not alter the pooled point estimates.
Therefore the inclusion of the trial with the lowest QUADAS
score did not alter pooled analysis or the validity of this
review. Publication bias remains an inherent weakness of all
meta-analyses, but visual inspection of funnel plots sug-
gested that it was not a major contributory factor. A limita-
tion of the present analysis was the historical nature of many
of the AAA endografts included in the analysed studies.
However, this does not represent a significant limitation to
the external validity of analysis regarding the accuracy of
endoleak diagnosis by USS or CT.
Although contrast-enhanced CT remains the gold-stan-
dard, the cumulative renal injury sustained due to repeated
nephrotoxic contrast agent administration is of great
concern. Preservation of renal function is vital to favourable
long-term outcomes following AAA repair.32 Although EVAR
attenuates the initial renal response associated with open
aneurysm repair,33 longer-term renal function undergoes
greater deterioration following EVAR compared to open
repair.34 Recently, concerns have been raised that this long-
term decline in renal function may be due to the repeated
use of nephrotoxic contrast agents in mandatory CT follow-
up of EVAR.35 Contrast-enhanced ultrasound utilises a non-
nephrotoxic contrast agent offering safer post-EVAR
surveillance. However, to replace the current gold-standard
for endoleak detection, any alternative imaging modality
must accurately identify endoleak with high sensitivity and
specificity. Our meta-analysis confirms the promise of
contrast-enhanced ultrasound in this regard. Focussed
prospective analysis of the sole use of CEUS as the diagnostic
imaging modality for post-EVAR endoleak is required.Conclusion
Although duplex ultrasound is often used to augment CT
scanning in post-EVAR follow-up, evidence suggests it is
unsuitable for sole use in endoleak detection after EVAR. Our
study confirms that CEUS offers promise as a safe and sensi-
tive modality for endoleak detection, potentially obviating
the need for patient exposure to high radiation doses and
nephrotoxic agents in recurrent CT imaging. However,
a cautious approach is required due to the high degree of
heterogeneity in the existing evidence. Furthermore, thismodality cannot always be used to assess many important
factors requiring re-intervention after EVAR including graft
migration and endograft kinking. Further research is
required to evaluate the clinical safety of CEUS and its utility
in the direction of post-EVAR re-intervention before it can be
recommended as the sole imaging modality after EVAR.
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